We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
GW Pharmaceuticals PLC | NASDAQ:GWPH | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 218.96 | 218.95 | 219.69 | 0 | 00:00:00 |
1. Name and Address of Reporting Person * Gover Justin D. | 2. Issuer Name and Ticker or Trading Symbol GW PHARMACEUTICALS PLC [ GWPH ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Executive Officer |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Ordinary Shares | 5/5/2021 | D | 222773 | D | (1)(2) | 0 | D | |||
Ordinary Shares | 5/5/2021 | D | 456048 | D | (1)(2) | 0 | I | By Justin D. Gover 2020 Irrevocable Trust dated December 14, 2020 | ||
Ordinary Shares | 5/5/2021 | D | 1867308 | D | (1)(2) | 0 | I | By the Gover Family Investment LLP |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Share Options | $0.0017 | 5/5/2021 | D | 17508 | (3) | 3/15/2022 | Ordinary Shares | 17508 | (3) | 0 | D | ||||
Share Options | $10.605 | 5/5/2021 | D | 75864 | (3) | 6/24/2025 | Ordinary Shares | 75864 | (3) | 0 | D | ||||
Share Options | $3.72 | 5/5/2021 | D | 213240 | (3) | 2/15/2026 | Ordinary Shares | 213240 | (3) | 0 | D | ||||
Share Options | $9.8117 | 5/5/2021 | D | 142344 | (3) | 1/6/2027 | Ordinary Shares | 142344 | (3) | 0 | D | ||||
Share Options | $9.6092 | 5/5/2021 | D | 147624 | (3) | 2/26/2028 | Ordinary Shares | 147624 | (3) | 0 | D | ||||
Share Options | $14.3342 | 5/5/2021 | D | 119472 | (3) | 3/1/2029 | Ordinary Shares | 119472 | (3) | 0 | D | ||||
Share Options | $14.645 | 5/5/2021 | D | 30936 | (3) | 6/14/2029 | Ordinary Shares | 30936 | (3) | 0 | D | ||||
Share Options | $0.0017 | 5/5/2021 | D | 22440 | (3) | (5) | Ordinary Shares | 22440 | (3) | 0 | D | ||||
Share Options | $0.0017 | 5/5/2021 | D | 34008 | (3) | (5) | Ordinary Shares | 34008 | (3) | 0 | D | ||||
Share Options | $0.0017 | 5/5/2021 | D | 226752 | (3) | (5) | Ordinary Shares | 226752 | (3) | 0 | D | ||||
Share Options | $0.0017 | 5/5/2021 | D | 12492 | (3) | (5) | Ordinary Shares | 12492 | (3) | 0 | D | ||||
Share Options | $0.0017 | 5/5/2021 | D | 55488 | (3) | (5) | Ordinary Shares | 55488 | (3) | 0 | D | ||||
Share Options | $0.0017 | 5/5/2021 | D | 287904 | (3) | (5) | Ordinary Shares | 287904 | (3) | 0 | D | ||||
Share Options | $0.0017 | 5/5/2021 | D | 479844 | (3) | (5) | Ordinary Shares | 479844 | (3) | 0 | D | ||||
Share Options | $0.0017 | 5/5/2021 | D | 164496 | (4) | (5) | Ordinary Shares | 164496 | (4) | 0 | D | ||||
Share Options | $0.0017 | 5/5/2021 | D | 263184 | (4) | (5) | Ordinary Shares | 263184 | (4) | 0 | D |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Gover Justin D. SOVEREIGN HOUSE, VISION PARK, HISTON CAMBRIDGE, X0 CB24 9BZ | X | Chief Executive Officer |
Signatures | ||
/s/ Justin D. Gover | 5/7/2021 | |
**Signature of Reporting Person | Date |
1 Year GW Pharmaceuticals Chart |
1 Month GW Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions